Mometasone furoate/formoterol combination therapy increases frequency of days/nights free of short-acting β<sub>2</sub>-agonist use
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-11-01
|
Series: | Allergy, Asthma & Clinical Immunology |